$1,500? Core Portfolio Cornerstone with a Moat for Investors
A single, moat-rich stock can anchor a long-term portfolio when you only have $1,500 to invest. This piece explains h...
Explore the question of which is better for daily expenses: cash back or points. Make informed choices to maximize your rewards potential.
27,346 articlesA single, moat-rich stock can anchor a long-term portfolio when you only have $1,500 to invest. This piece explains h...
Two pharma giants flashed a golden cross this month, but the stories behind AbbVie and Baxter diverge sharply for inc...
Investors are weighing Amazon's retail muscle against cloud and AI competition. This guide asks: could amazon actuall...
Amazon's liquidity position is tightening as it pours billions into AI infrastructure. Investors pore over cash metri...
Analysts project NVIDIA’s free cash flow to climb sharply as AI deployments accelerate, potentially changing how inve...
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
PSEG's steady, regulated core supports its payout, but 2025 earnings hinge on rate cases, fuel costs, and clean energ...
A healthcare-focused dividend stock surged last year, outpacing the Nasdaq and delivering solid income. Analysts see ...
A recent move shows Bamco expanding its exposure to FactSet, highlighting the power of subscription-based data platfo...
Mortgage lenders accelerate the shift to digital promissory notes as funding timelines tighten. The trend signals eno...
Bitwise’s Q2 2026 review shows a third straight down quarter for its Large Cap Crypto Index, yet on-chain activity an...
As markets enter 2026, a century of stock market data underpins a new wave of strategy. This piece distills three les...